GCTK GlucoTrack, Inc.
$2.05▲ +19.88%
Healthcare
Other
After hours
$2.05▲ +0.05%
Oct 28, 4:15 PM ET
Volume 27.90M
Avg Volume (10D) 4.00M
Key Metrics & Fundamentals
Market Cap
$2.43M
P/E Ratio
0.1
Div Yield
0.00%
52W Range
0.75 - 207.12
% vs 50 MA
-29.85%
% vs 200 MA
-86.33%
RSI-14
53.0
MACD Histogram
+0.1800
Beta (1Y vs SPY)
3.23
Free Cash Flow
-$3.62M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.38M
COGS
–
Operating Exp
$3.40M
Operating Income
-$3.40M
EBIT
-$3.40M
Pretax Income
-$3.81M
Net Income
-$3.81M
EPS (Diluted)
-0.76
Price & Volume History
Loading chart…
Recent News
Glucotrack, Inc. Announces Reverse Stock Split
Business Wire · Oct 22, 2026 9:00 AM ET
Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
Business Wire · Oct 14, 2026 9:00 AM ET
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
Business Wire · Oct 1, 2026 5:15 PM ET
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
Business Wire · Sep 30, 2026 9:00 AM ET
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
Business Wire · Sep 25, 2026 9:00 AM ET
BC-Most Active Stocks
Associated Press · Sep 24, 2026 10:30 AM ET
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
Business Wire · Sep 24, 2026 8:45 AM ET
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
Business Wire · Sep 23, 2026 4:30 PM ET
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
Business Wire · Sep 23, 2026 9:00 AM ET
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
Business Wire · Sep 18, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See GCTK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.